News and Commentary

Maine Gets HCFA Waiver for Drug Discount Program

The Health Care Financing Administration has given Maine officials clearance to offer a discount prescription program to 200,000 people without a pharmacy benefit. The program was developed after the pharmaceutical industry won a court injunction suspending Maine's new law requiring the state to negotiate rebates and discounts for all uninsured residents.

The latest program, modeled on one in Vermont, would apply to individuals and families that earn up to 300 percent of poverty but do not qualify for Medicaid. HCFA granted the state a waiver to allow it to offer prescription products at a price equivalent to what its Medicaid program pays — in essence, a discount of 25 percent. The Vermont law has withstood a federal court challenge from the pharmaceutical industry.


A Conversation With Marc Harrison, MD
By Interview by Peter Wehrwein
A Conversation with J. Kevin Croston, MD, and Craig Samitt, MD
By Interview by Peter Wehrwein
A Conversation with Andy Slavitt
By Interview by Richard Mark Kirkner

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report